Latest Commercialisation Strategy News

Li-S Energy has secured ISO 9001:2015 certification for its lithium foil production in Geelong and completed its first commercial shipment to a leading Australian battery research institution, marking a key step in establishing a sovereign lithium foil supply chain.

Pure Resources and Rice University have secured 'Awardable' status on the DARPA ERIS Marketplace for their advanced Carbon Nanotube Fibre 3D thermal management technology, positioning them for potential US Department of Defense contracts.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

Memphasys has locked in a 12-month exclusive supply agreement with Monash IVF for its Felix™ sperm selection system, marking its biggest commercial contract to date and setting a foundation for recurring revenue.

LTR Pharma has confirmed it disclosed a binding US commercialisation agreement for ROXUS promptly after signing, responding to ASX scrutiny over pre-announcement trading activity.

dorsaVi has raised $500,000 through the exercise of 25 million unlisted options by key shareholders, reinforcing confidence in its advanced AI and neuromorphic semiconductor projects. The capital will accelerate development of its 22nm node technology targeting medical and industrial robotics markets.

PMET Resources has endorsed NRW Holdings’ ALi® atmospheric leach process for producing battery-grade lithium carbonate, highlighting its economic and environmental advantages. NRW is advancing commercialisation with ongoing testing and development plans.

Iondrive Limited’s proprietary IONSolv™ process has independently achieved a 93.5% recovery rate for dysprosium from US commercial e-waste, vastly outperforming previous techno-economic assumptions and extending its rare earth extraction capabilities into heavy rare earths.

LTR Pharma has locked in Strive Specialties as its exclusive US pharmacy fulfilment partner for ROXUS, marking a critical step towards commercial launch in the US erectile dysfunction market.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

InFocus Group Holdings is streamlining its software development operations by divesting Prodigy9 and consolidating under Onify, aiming for immediate cost savings and a leaner, AI-native delivery model.

Yojee Limited has secured Wayfinder Cargo Solutions as its second commercial customer for the MOSAIC freight forwarding platform, marking full operational coverage across all freight modes and directions ahead of its full commercial launch.